Savant Capital LLC raised its position in shares of McKesson Corp. (NYSE:MCK) by 5.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,618 shares of the company’s stock after buying an additional 126 shares during the period. Savant Capital LLC’s holdings in McKesson Corp. were worth $489,000 as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in the stock. Kelman Lazarov Inc. acquired a new stake in shares of McKesson Corp. during the second quarter worth about $115,000. Welch Group LLC acquired a new stake in shares of McKesson Corp. during the second quarter worth about $126,000. Seven Eight Capital LLC acquired a new stake in shares of McKesson Corp. during the first quarter worth about $110,000. Baker Ellis Asset Management LLC boosted its stake in shares of McKesson Corp. by 15.7% in the first quarter. Baker Ellis Asset Management LLC now owns 735 shares of the company’s stock worth $116,000 after buying an additional 100 shares during the period. Finally, Winslow Evans & Crocker Inc. boosted its stake in shares of McKesson Corp. by 14.1% in the second quarter. Winslow Evans & Crocker Inc. now owns 816 shares of the company’s stock worth $152,000 after buying an additional 101 shares during the period. 84.77% of the stock is owned by institutional investors.
Shares of McKesson Corp. (NYSE:MCK) traded up 0.01% during mid-day trading on Wednesday, hitting $165.67. 1,555,167 shares of the stock were exchanged. The stock has a market cap of $37.39 billion, a PE ratio of 17.20 and a beta of 0.93. McKesson Corp. has a 12 month low of $148.29 and a 12 month high of $202.20. The stock’s 50 day moving average is $177.66 and its 200-day moving average is $179.30.
McKesson Corp. (NYSE:MCK) last released its quarterly earnings data on Wednesday, July 27th. The company reported $3.50 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.17. The firm earned $49.73 billion during the quarter, compared to the consensus estimate of $50.32 billion. McKesson Corp. had a return on equity of 31.62% and a net margin of 1.15%. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $3.14 earnings per share. On average, analysts anticipate that McKesson Corp. will post $13.63 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, October 3rd. Investors of record on Thursday, September 1st were issued a $0.28 dividend. The ex-dividend date was Tuesday, August 30th. This represents a $1.12 annualized dividend and a dividend yield of 0.68%. McKesson Corp.’s payout ratio is currently 11.64%.
A number of brokerages have recently issued reports on MCK. FBR & Co reaffirmed a “buy” rating and issued a $210.00 price objective on shares of McKesson Corp. in a research note on Wednesday, June 29th. JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of McKesson Corp. in a research note on Thursday, June 30th. Bank of America Corp. reiterated a “hold” rating on shares of McKesson Corp. in a report on Thursday, June 30th. Robert W. Baird reiterated a “buy” rating and set a $220.00 price target on shares of McKesson Corp. in a report on Wednesday, June 29th. Finally, Deutsche Bank AG reiterated a “buy” rating on shares of McKesson Corp. in a report on Monday, July 18th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $201.17.
In related news, Chairman John H. Hammergren sold 100,500 shares of McKesson Corp. stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $184.22, for a total value of $18,514,110.00. Following the completion of the sale, the chairman now directly owns 100,500 shares in the company, valued at $18,514,110. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Marie L/Ca Knowles sold 915 shares of McKesson Corp. stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $192.73, for a total value of $176,347.95. The disclosure for this sale can be found here. 1.15% of the stock is owned by corporate insiders.
About McKesson Corp.
McKesson Corporation (McKesson) is a pharmaceutical distribution services and information technology company. The Company delivers an offering of pharmaceuticals and medical supplies. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The Distribution Solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products around the world and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices.
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corp. (NYSE:MCK).
Receive News & Ratings for McKesson Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corp. and related companies with MarketBeat.com's FREE daily email newsletter.